Bundibugyo at the border: The 2026 Ebola outbreak and the case for pre-emptive countermeasure equity
Travel Medicine and Infectious Disease · 2026
DOI: 10.1016/j.tmaid.2026.103018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Travel Medicine and Infectious Disease, 2026. Verfasst von Adamu Safiyanu Maikifi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics and Pharm. Tech, Gombe State University, Gombe, Nigeria. Electronic address: safimkf@gsu.edu.ng. Hauptthemen laut MEDLINE: Hemorrhagic Fever, Ebola, Disease Outbreaks. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The 2026 Ebola outbreak caused by Bundibugyo ebolavirus in the Democratic Republic of the Congo and Uganda exposes a persistent structural flaw in global health security: preparedness remains overwhelmingly reactive and pathogen-specific. Despite the $518 million Africa CDC-WHO joint continental plan, no licensed BDBV vaccine or therapeutic is available; a 21-day (three-week) detection delay and cross-border transmission expose inadequate inter-epidemic investment in non-Zaire ebolavirus countermeasures. We argue for sustained, ring-fenced financing, institutionalised cross-border coordination, species-inclusive diagnostics, and real-time genomic data sharing to move African Ebola preparedness from reactive to pre-emptive.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics and Pharm. Tech, Gombe State University, Gombe, Nigeria. Electronic address: safimkf@gsu.edu.ng.
- Department of Biochemistry, Faculty of Sciences, Chulalongkorn University, Bangkok, Thailand.
- School of Global Health, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
- Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.
Zitieren
APA
Maikifi, A. S., Auwal, A. R., Ishak, A. S., & Jibo, A. G. (2026). Bundibugyo at the border: The 2026 Ebola outbreak and the case for pre-emptive countermeasure equity. Travel Medicine and Infectious Disease. https://doi.org/10.1016/j.tmaid.2026.103018
Vancouver
Maikifi AS, Auwal AR, Ishak AS, Jibo AG. Bundibugyo at the border: The 2026 Ebola outbreak and the case for pre-emptive countermeasure equity. Travel Medicine and Infectious Disease. 2026. doi:10.1016/j.tmaid.2026.103018
BibTeX
@article{Maikifi2026,
author = {Maikifi, Adamu Safiyanu and Auwal, Auwal Rabiu and Ishak, Abubakar Sunusi and Jibo, Abdulrahman Garba},
title = {Bundibugyo at the border: The 2026 Ebola outbreak and the case for pre-emptive countermeasure equity},
journal = {Travel Medicine and Infectious Disease},
year = {2026},
doi = {10.1016/j.tmaid.2026.103018}
}
EUVIMED